Medtronic Wins European Patent Fight Against Edwards

Medtronic (NYSE: MDT  ) has won an intellectual property victory on the other side of the Atlantic Ocean. The company announced today that the European Patent Office has invalidated and revoked a patent, the Spenser, held by Edwards Lifesciences (NYSE: EW  ) for an aortic valve replacement system. The decision represents a sort of reversal; last August, Edwards won an injunction in Germany that Medtronic's CoreValve transcatheter aortic valve infringed on the Spenser patent.

In the press release announcing the news, Medtronic quoted its Senior Vice President John Liddicoat as saying that the court's decision "will ensure that patients across Europe who need aortic valve replacement will have access to this life-saving therapy."

The two companies have been battling over transcatheter aortic valve patents for some time. This past January, a federal court jury in Delaware found that CoreValve infringed on a different Edwards patent, the Cribier. Medtronic was found liable for over $393 million in damages; the firm has said it will appeal the decision.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2867625, ~/Articles/ArticleHandler.aspx, 8/2/2014 5:00:20 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement